FDA 483 - Fukuzyu Pharmaceutical Co., Ltd. - January 19, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Fukuzyu Pharmaceutical Co., Ltd. in Toyama, Japan, an API manufacturer, was cited for four significant observations during an FDA inspection. The firm failed to conduct thorough investigations for out-of-specification results and critical deviations, and exhibited inadequate cleaning and maintenance of shared production equipment. Additionally, the inspection revealed incomplete validation of analytical methods and insufficient control over computerized systems and electronic records in the QC laboratory, indicating serious deficiencies in quality control and data integrity.
ID · 66552528-7f7e-40bd-b48e-8d2fbc441945